TDW Pharmaceuticals
Business Services · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4f No.631 Ruiguang Rd Neihu Dist Taipei,...Website
www.tdwpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About TDW Pharmaceuticals
TDW Pharmaceuticals, Inc. is a Taiwan-based company founded in 2003. TDW is currently developing ADI-PEG 20 for the treatment of hepatocellular carcinoma (HCC) in Taiwan. The company recently completed a randomized Phase II study for subjects with unresectable HCC in March 2008. These study results confirmed the safety and efficacy of ADI-PEG 20 as a treatment for HCC. TDW is now working with Polaris Group to initiate a Phase III, multi-national, multi-center study for HCC in 2009. TDW is also developing Uricase-PEG 20 for the treatment of gout and tumor lysis syndrome in Taiwan. The company expects to initiate a Phase I study for gout in Taiwan in 2009. As a member of the Polaris Group companies, TDW is responsible for conducting clinical studies in the Asian-Pacific region.Explore more
Popular SearchesTDW Pharmaceuticals IncSIC Code 87,873NAICS Code 54,541Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TDW Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on TDW Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once TDW Pharmaceuticals has new funding data
Check out if TDW Pharmaceuticals is spiking on competitors!
Click to see if TDW Pharmaceuticals had a recent Job posting/layoffs
TDW Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at TDW Pharmaceuticals
Product Launch: Get notified when TDW Pharmaceuticals launches new products
Check if TDW Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined TDW Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to TDW Pharmaceuticals
Compare insights from companies similar to TDW Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
TDW Pharmaceuticals
<$5M
1-10
Private
-
2003
N/A
Company Profile Activity
Activity Insights
TDW Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
TDW Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about TDW Pharmaceuticals.
TDW Pharmaceuticals Tech Stack
A closer look at the technologies used by TDW Pharmaceuticals
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding TDW Pharmaceuticals
Sign Up For FreeTo access detailed company insights
TDW Pharmaceuticals, Inc. is a Taiwan-based company founded in 2003. TDW is currently developing ADI-PEG 20 for the treatment of hepatocellular carcinoma (HCC) in Taiwan. The company recently completed a randomized Phase II study for subjects with unresectable HCC in March 2008. These study results confirmed the safety and efficacy of ADI-PEG 20 as... Read More
